KCT0003391招募中未知
Chronic Cerebrovascular Disease Oriented Biobank Consortium Operation
Ajou University Hospital0 个研究点目标入组 945 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 945
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 40(Year) 至 90(Year)（—）
- 性别
- All
入选标准
- •? Person aged 40 years or below 90 years based on registration time (Baseline, B-1)
- •Do not calculate the age of the U.S., and both the age of resident registration and actual age are over 40 years old.
- •? person who can have sufficient hearing and vision to perform a neuropsychiasis test
- •However, even corrected hearing and vision may participate if the performance of the neuro-psychoactic examination is not impaired
- •? Person who have no medical condition in brain imaging (MRI, PET) examinations that can participate in neuroimaging studies - person without an artificial heart monitor, an aneurysm clip, an artificial heart valve, or an ear transplant
- •? Person who has agreed to participate in the research including collection of blood, treatment and survey
- •A person who can be accompanied by the same guardian at all times during the study period, and is recommended to have the same guardian come at each progress trace
- •The caregiver is aware of the condition of the patient before the occurrence except the caregiver, and is able to observe the occurrence of the patient for two hours or more a day.
- •? person whose medical history is stable without increasing the amount of medication within three months of participation. However, some changes in the treatment guidelines may be accepted based on the judgment of the researchers.
排除标准
- •? If the subjects of all target groups are diagnosed with neurological diseases and vascular dementia, they can not participate in this research.
- •A. Other vascular dementia such as multi-infarch disease and strategic infarction dementia due to multiple cerebral infarction
- •B. Brain lesions with neuropathy
- •ex) Huntington's disease, Normal pressure hydrocepalus, Brain tumor, Progressive supranuclear palsy
- •C. Spastic diseases that can cause large releases (GTCS)
- •D. Brain diseases that can cause secondary dementia, such as carbon monoxide poisoning or alcoholic dementia.
- •? Person with evidence of infection, infarction, and other local lesions in brain MRI conducted during Screening or Baseline.
- •However, MRI performed during Screening could participate if there were less than 5 lacune multiple heat sources.
- •? Person with major mental disorders, such as schizophrenia, major depression, and bipolar disorder, described by DSM-III within the past two years.
- •? Person with an unadjusted sleep disorder, anxiety or behavioral disorder within three months of the screening time.
- •? At the time of screening, who has a history of abuse or dependence on alcohol or drugs within the past two years.
- •? Person who is deemed difficult to comply with the research results due to the following diseases :
- •A. Person diagnosed with malignant tumor within 3 years of the screening time. However, it excludes cancer that can be detected and treated in the early stages and determines if it is a mild case based on the judgment of the researchers. If you have been diagnosed with cancer, but have been completely cured at this point, you can register
- •B. A medical condition that can cause mental abnormalities - those who have thyroid, liver or kidney disease.
- •Evaluation of a subject's disease is based on the medical judgment of the researchers
- •? Except in cases where drug use, such as antidepressants, antipsychotics, antianxiety drugs, or sedation sleep pills, can interfere with neuropsychological evaluation
- •A person who is likely to be pregnant or breast-feed May participate after more than two years of menopause or infertility
- •? Who is participating in other drug research. However, those who participate in observational studies without medication may participate in this study
- •If PET scan can not be performed. Includes but is not limited to (pastrophobia, not limited to)If there is or is suspected to be an overresponsiveness of 18 F-flutemetamol or its subtants (e.g. polysorbate 80).
研究者
相似试验
已完成
不适用
Intervention Project on cerebrovascular diseases and dementia in the district of EbersbergF00F01F02F03G30G31G45I61I62I63I64Dementia in Alzheimer diseaseDementia in other diseases classified elsewhereUnspecified dementiaAlzheimer diseaseOther degenerative diseases of nervous system, not elsewhere classifiedTransient cerebral ischaemic attacks and related syndromesIntracerebral haemorrhageOther nontraumatic intracranial haemorrhageVascular dementiaStroke, not specified as haemorrhage or infarctionCerebral infarctionDRKS00011348INVADE gemeinnützige GmbH - Institut für Versorgungsforschung23,888
进行中（未招募）
不适用
National Cerebral and Cardiovascular Center (NCVC) Stroke RegistryStroke, AcuteNCT02251665National Cerebral and Cardiovascular Center, Japan5,374
Unknown
不适用
Carotid Endarterectomy and Carotid Artery Stenting in BrazilArterial Diseases, CarotidNCT02538276University of Sao Paulo500
招募中
2 期
Cerebrovascular reserve and white matter disease in patients with chronic anemia. (IMPROvE)NL-OMON48763Academisch Medisch Centrum140
招募中
不适用
Cerebrovascular reserve and white matter disease in patients with chronic anemiaNL-OMON27211AMC140